Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive ...

Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory ...

Pfizer is pursuing pipeline expansions through the Metsera acquisition and a major licensing deal with 3SBio. Find out why ...

A research team has demonstrated that thin films of ruthenium dioxide (RuO₂) exhibit altermagnetism—the defining property of ...

The important questions for CBSE Class 12 are curated carefully based on past exam patterns, high-weightage chapters, and the latest sample papers. These questions help students practise concepts that ...

Study did not demonstrate statistically significant improvement on primary endpoint of reduction in anxiety as measured by SUDS scores compared to placeboFavorable safety and tolerability data were ...

But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion ...

A tragic mass shooting at Brown University's engineering school on Saturday claimed the lives of two students and injured ...

Consistent OS benefit in an Asian subset with a strong HR of 0.69 for non-squamous patients, and meaningful safety advantage ...

Drake University has announced it is expanding its “faculty-led” study abroad programs past Europe and into South Korea, with ...

Zoliflodacin is an oral spiropyrimidinetrione antibiotic with activity against multidrug-resistant strains of Neisseria gonorrhoeae.